ID
34364
Descripción
Study ID: 101682 Clinical Study ID: B2E101682 Study Title: A randomised, double-blind, placebo-controlled, parallel group study to examine the safety, tolerability, and pharmacokinetics of repeat inhaled doses of GSK159797 in healthy subjects. Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: milveterol Trade Name: milveterol Study Indication: Pulmonary Disease, Chronic Obstructive. This form contains information about non-serious adverse events and should only be completed in case of occurence of non-serious adverse events.
Palabras clave
Versiones (2)
- 16/1/19 16/1/19 -
- 16/1/19 16/1/19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
16 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Safety, tolerability and pharmacokinetics of repeat inhaled doses of milveterol in healthy subjects (Study ID: 101682)
Non-Serious Adverse Events
- StudyEvent: ODM
Descripción
Non-Serious adverse events
Alias
- UMLS CUI-1
- C1518404
Descripción
If YES, indicate below
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1518404
Descripción
Diagnosis or signs/symptoms of NSAE
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0011900
- UMLS CUI [1,2]
- C0037088
- UMLS CUI [1,3]
- C1518404
Descripción
Date of onset NSAE
Tipo de datos
date
Unidades de medida
- dd.mm.yyyy
Alias
- UMLS CUI [1,1]
- C0574845
- UMLS CUI [1,2]
- C1518404
Descripción
Time of onset NSAE
Tipo de datos
time
Unidades de medida
- hh:mm
Alias
- UMLS CUI [1,1]
- C0449244
- UMLS CUI [1,2]
- C1518404
Descripción
Maximum Intensity NSAE
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0518690
- UMLS CUI [1,2]
- C1518404
Descripción
Outcome SAE
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C1705586
- UMLS CUI [1,2]
- C1518404
Descripción
Date of resolution
Tipo de datos
date
Unidades de medida
- dd.mm.yyyy
Alias
- UMLS CUI [1,1]
- C2985918
- UMLS CUI [1,2]
- C1518404
Descripción
Time of resolution
Tipo de datos
time
Unidades de medida
- hh:mm
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C2699488
- UMLS CUI [1,3]
- C1518404
Descripción
Investigational drug, change of dose as a result of NSAE
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0013230
- UMLS CUI [1,2]
- C1608430
- UMLS CUI [1,3]
- C1518404
Descripción
Withdrawal from study as result of NSAE
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1710677
- UMLS CUI [1,2]
- C1518404
Descripción
Relationship to investigational product
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0085978
- UMLS CUI [1,3]
- C0013230
Descripción
In this study, the answer 'No' was preselected.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1704788
- UMLS CUI [1,2]
- C1710056
Similar models
Non-Serious Adverse Events
- StudyEvent: ODM
C0037088 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,3])
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C2699488 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,3])
C1608430 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,3])
C1518404 (UMLS CUI [1,2])
C0085978 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C1710056 (UMLS CUI [1,2])